US Patent Issued to AXSOME THERAPEUTICS on April 8 for "Pharmaceutical compositions comprising a tolfenamic acid" (New York Inventor)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,693, issued on April 8, was assigned to AXSOME THERAPEUTICS INC. (New York).

"Pharmaceutical compositions comprising a tolfenamic acid" was invented by Herriot Tabuteau (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migrain...